We would like to express our heartfelt gratitude to SoftQ sp. z o.o. for their continuous support and dedicated efforts in successfully publishing the Journal of Rare Cardiovascular Diseases over the years. Their contributions have been instrumental in shaping the journal into a trusted platform for sharing valuable research and insights into rare cardiovascular conditions.
As we look toward the future, we are pleased to announce that starting from 2021 onwards, the Journal of Rare Cardiovascular Diseases will be published with the support of MedinLin Soft. This transition marks an exciting new chapter for the journal, enabling us to further enhance our reach, improve publication processes, and continue our mission of disseminating high-quality research in the field of rare cardiovascular diseases.
We extend our sincere thanks to all our readers, authors, and contributors for their continued trust and support. Together, we aim to advance the understanding and management of rare cardiovascular diseases and foster impactful collaboration within the global medical community.
Thank you for being a part of our journey.
Warm regards,
The Editorial Team
Journal of Rare Cardiovascular Diseases
